In its ongoing commitment to advancing the field of aesthetic medicine, Ko Academy, a training facility under Dr. Ko Skin Specialist, has launched the 3rd edition of Asia Dermatology & Aesthetic Medicine Summit 2024 (ADAMS 2024) at Shangri-La Kuala Lumpur taking place on July 27-28, 2024.
The conference is an initiative to boost dermatology and aesthetic medicine in Malaysia and offers medical practitioners a platform to share global knowledge and insights.
ADAMS 2024, themed ‘A Symphony of Beauty: The Union of Science & Art,’ attracted over 600 conference delegates, including doctors and practitioners, and featured a lineup of speakers from around the world in the dermatology and aesthetic fields.
Ko Academy highlighted the importance of regulations and policies in the summit with a forum titled ‘Building Trust Through Regulations: Promoting Safe Practices.’
Alongside the conference was an exhibition hall that featured 50 exhibition booths displaying a wide range of brands and products in dermatology and medical aesthetics.
The lineup of speakers from Ministry of Health, included Vicknesh Krishnan, vice president of healthcare at Malaysia Healthcare Travel Council; Nashirah Naiimi, head of strategic planning branch, policy and strategic planning division at Medical Device Authority; and Najmi Ismail, senior assistant director of medical legislative branch.
In his speech, Dato’ Dr. Ko Chung Beng, founder and CEO of Dr. Ko Skin Specialist and organizing chairman of ADAMS 2024, said the summit placed a strong emphasis on the necessity of integrating artistic vision with scientific rigor.
“We recognize that our commitment goes beyond merely advancing aesthetic practices. It involves harmonizing artistic vision with scientific precision to uphold the highest standards of safety and quality.
“Just as a symphony blends different elements to create beauty, our field thrives on this integration, building trust with our patients and elevating the quality of care we provide,” he said.
The global aesthetic medicine market valued at about USD 19.2 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 12% from 2024 to 2032. The non-surgical segment is expected to reach USD 41.8 billion by 2032, reflecting a significant shift towards less invasive procedures.
In Malaysia, the aesthetic medicine sector has shown remarkable growth. The revenue of aesthetic medical providers increased at a CAGR of 30.8% from 2019 to 2021. In 2022, the domestic market was estimated at RM468.8 million, and it is anticipated to grow at a CAGR of 18.8%, rising from RM366.3 million in 2021 to RM1.03 billion by 2027.
With such a positive outlook, the Malaysian aesthetic medicine market is poised for continued growth, driven by innovation, regulatory support and increasing consumer demand. This promising future underscores the potential for Malaysia to become a regional leader in aesthetic medicine, offering world-class treatments and attracting global attention.
 was held at Shangri-La Kuala Lumpur on 27-28, 2024.){kind=link}